Stocks · Health care · Biological Products, (No Diagnostic Substances)

Amgen

AMGN Clue Score50
United States Fiscal year ends December CIK 0000318154 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Rachna Khosla
11 Aug 2026
SVP, Business Development
Sell
2,000
$412.57
$825.13K
Nancy A. Grygiel
4 May 2026
SVP & CCO
Sell
1,237
$323.73
$400.45K
Matthew C. Busch
19 Feb 2026
VP, Finance & CAO
Sell
1,000
$375.79
$375.79K
Murdo Gordon
12 Nov 2025
EVP, Global Commercial Ops
Sell
6,879
$336.83
$2.32M
Rachna Khosla
12 Nov 2025
SVP, Business Development
Sell
890
$336.24
$299.26K

What was left out

Form 4 filings counted 86
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 510,711
History held since 4 Oct 2006